2021
REVeAL-HF Design and Rationale of a Pragmatic Randomized Controlled Trial Embedded Within Routine Clinical Practice
Ahmad T, Yamamoto Y, Biswas A, Ghazi L, Martin M, Simonov M, Hsiao A, Kashyap N, Velazquez EJ, Desai NR, Wilson FP. REVeAL-HF Design and Rationale of a Pragmatic Randomized Controlled Trial Embedded Within Routine Clinical Practice. JACC Heart Failure 2021, 9: 409-419. PMID: 33992566, DOI: 10.1016/j.jchf.2021.03.006.Peer-Reviewed Original ResearchConceptsHeart failurePatient outcomesClinical decision makingN-terminal pro-B-type natriuretic peptide levelsPro-B-type natriuretic peptide levelsPragmatic Randomized Controlled TrialIntravenous diuretic agentsNatriuretic peptide levelsRandomized Controlled TrialsRoutine clinical practiceEvidence-based interventionsElectronic health recordsControlled TrialsPatient populationAccurate prognosticationCommon causeDiuretic agentsPeptide levelsClinical practicePg/TrialsHealth recordsSignificant riskMortalityOutcomes
2019
Evaluating the Impact of a New Smartphone Texting Tool on Patient Care in Obstetrics, an Emergent Healthcare Setting
Feinberg J, Shaw S, Kashyap N, Illuzzi J, Campbell K, Hsiao A, Pettker C. Evaluating the Impact of a New Smartphone Texting Tool on Patient Care in Obstetrics, an Emergent Healthcare Setting. Applied Clinical Informatics 2019, 10: 879-887. PMID: 31747710, PMCID: PMC6867929, DOI: 10.1055/s-0039-1700868.Peer-Reviewed Original ResearchConceptsPatient careText messaging systemEmergent settingSustained improvementYale-New Haven HospitalPoor patient outcomesTimely evaluationNurses' knowledgePatient outcomesTexting systemDecrease riskNew Health Insurance PortabilityHealthcare settingsObstetricsCareHealth Insurance PortabilityWhitney testHospitalClinical workflowMonthsWilcoxon-MannOpen-ended questionsInsurance PortabilityLikert scalePotential benefits